A Post-Marketing Surveillance Study to Evaluate Performance of the EXIMO™ Blood Glucose Monitoring System

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 5

Abstract

Introduction: The performance of Blood Glucose Monitoring System (BGMS) is critical as the information provided by the system guide the patient or health care professional in making treatment decisions. However, besides evaluating accuracy of the BGMS in laboratory setting, it is equally important that the intended users (healthcare professionals and patients) should be able to achieve blood glucose measurements with similar level of high accuracy. Aim: To assess the performance of EXIMO™ (Meril Diagnostics Pvt. Ltd., Vapi, Gujarat, India) BGMS as per International Organization for Standardization (ISO) 15197:2013 section 8 user performance criteria. Materials and Methods: This was a non-randomized and postmarketing study conducted at a tertiary care centre of India. A total of 1005 patients with diabetes themselves performed fingertip blood glucose measurement using EXIMO™ BGMS. Immediately after capillary blood glucose measurement using the blood glucose monitoring system, venous blood sample from each patient was obtained by a trained technician which was assessed by reference laboratory method- Cobas Integra 400 plus (Roche Instrument Centre, Rotkreuz, Switzerland). All the blood glucose measurements assessed by EXIMO™ were compared with laboratory results. Performance of the system was assessed as per ISO 15197:2013 criteria using Bland-Altman plot, Parkes-Consensus Error Grid (CEG) and Surveillance Error Grid analyses (SEG). Results: A total of 1005 patients participated in the study. Average age of the patients was 44.93±14.65 years. Evaluation of capillary fingertip blood glucose measurements demonstrated that 95.82% measurements fulfilled ISO 15197:2013 section 8 user performance criteria. All the results lie within clinically noncritical zones; Zone A (99.47%; n=1000) and Zone B (0.53%; n=05) of the CEG analysis. As per SEG analysis, majority of the results fell within “no-risk” zone (risk score 0 to 0.5; 90.42%). Conclusion: The result of the study confirmed that intended users are able to obtain accurate glucose measurements when operating EXIMO™ BGMS, given only the instructions and training materials routinely provided with the system, in clinical practice.

Authors and Affiliations

Sonia R. Chandnani, C. D. Ramakrishna, Bhargav A. Dave, Pankaj S. Kothavade, Ashok S. Thakkar

Keywords

Related Articles

Efficacy of Electroconvulsive Therapy in Various Psychiatric Disorders: A Hospital Based Longitudinal Follow-up Study

ABSTRACT Introduction: Electroconvulsive Therapy (ECT) is one of the neurobiological therapies available for the treatment of various psychiatric disorders especially those resistant to pharmacotherapy or, where a rapid...

Prevalence of Gestational Glucose Intolerance and Gestational Diabetes in a Tertiary Care Centre in Northern India

ABSTRACT Introduction: Many centres in India have adopted a one-step method known as Diabetes in Practice Study Group in India (DIPSI) criterion to diagnose Gestational Diabetes Mellitus (GDM). Prevalence of GDM is incre...

Juvenile Hyaline Fibromatosis- A Rare Autosomal Recessive Disease

Systemic hyalinosis is inherited as an autosomal recessive disease. It may also be referred to as Fibromatosis hyalinica multiplex juvenilis and Murray-Puretic-Drescher syndrome. A four and a half-year-old female child p...

Does the Addition of Melatonin to Quadruple Therapy Increases the Eradication Rate of Helicobacter pylori? A Double-Blind Randomized Clinical Trial

ABSTRACT Introduction: The failure in eradication of Helicobacter pylori (H.pylori) using standard treatments is a common concern all over the world. Limited data have shown efficacy of melatonin against H.pylori in vitr...

Attitudes of Mashhad Public Hospital's Nurses and Midwives toward the Causes and Rates of Medical Errors Reporting

Introduction: Patient’s safety is one of the main objective in healthcare services; however medical errors are a prevalent potential occurrence for the patients in treatment systems. Medical errors lead to an increase in...

Download PDF file
  • EP ID EP342246
  • DOI 10.7860/JCDR/2017/26596.9892
  • Views 71
  • Downloads 0

How To Cite

Sonia R. Chandnani, C. D. Ramakrishna, Bhargav A. Dave, Pankaj S. Kothavade, Ashok S. Thakkar (2017). A Post-Marketing Surveillance Study to Evaluate Performance of the EXIMO™ Blood Glucose Monitoring System. Journal of Clinical and Diagnostic Research, 11(5), 29-32. https://europub.co.uk/articles/-A-342246